Subject: PSID Tests Massive New Market for its Firefly DX BICX Bounces Back Last Week Up 30%

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
PSID Tests Massive New Market for its Firefly DX BICX Bounces Back Last Week Up 30%
Hot Stock to WatchHot Stock to Watch


Company: PositiveID Corporation (OTCQB: PSID)


End of Day:

Price: 0.0277

Change (%): + 0.0005 (1.84)

Volume: 3,263,896
PSID Chart

PositiveID Expands Firefly Dx Testing Capabilities for Hospital Acquired Infection Market

Company Adds C. diff to the List of Pathogens Successfully Detected on Its Firefly Dx Prototype System

DELRAY BEACH, Fla., Sept. 08, 2015 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today that it has successfully detected Clostridium difficile (“C. diff”) on its Firefly Dx polymerase chain reaction (“PCR”) breadboard prototype pathogen detection system (“prototype system”) in less than 20 minutes. The C. diff assay, provided to the Company for testing by partner GenArraytion, Inc., is a more comprehensive and specific test than many other C. diff assays on the market as it tests for the C. diff chromosome as well as both Toxin A and Toxin B.

C. diff is a bacterium that most often affects older patients in hospitals or long-term care facilities after antibiotic use, and causes symptoms ranging from diarrhea to lethal inflammation of the colon. More than 500,000 people get sick each year from C. diff, which, like many hospital-acquired infections, has become more frequent, severe and difficult to treat.

Continue Reading

Top PerformerYesterday's Top Performer

Company:
BioCorRx Inc. (OOTCQB: BICX)


End of Day:

Price: 0.049

Change (%): + 0.0115 (30.67)

Volume: 153,800
BICX Chart

BioCorRx, Inc. ® (OTCQB: BICX is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program®, a Medication-assisted Treatment (MAT) program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program.

Company Information Sheet


Other Small Cap News


Company: New Western Energy Corporation (Pink Sheets: NWTR)


New Western Energy Completes Acquisition of Oil and Gas Leases in Osage County, Oklahoma Comprising 480 Acres, Consisting of 17 Wells

IRVINE, Calif., Sept. 08, 2015 (GLOBE NEWSWIRE) -- New Western Energy Corporation (OTC:NWTR), an independent energy company engaged in the acquisition, exploration, development and production of oil and gas in North America, today announced it has completed the acquisition of oil and gas leases located in Osage County, Oklahoma Comprising 480 contiguous acres, consisting of 17 Wells.

“We are very pleased to acquire additional leases with working production and strong potential for redevelopment work,” said Javan Khazali, CEO of New Western Energy. “We are continuing to execute on our plan to acquire distressed assets and increase our portfolio of leases and production,” he added.

Continue Reading


Company: Duos Technologies Group (OTCQB: DUOT)


Duos Technologies Awarded Technology Services Contract for Major National Retailer

Data Center Technology Services Division

JACKSONVILLE, FL--(Marketwired - September 08, 2015) - Duos Technologies Group (OTCQB: DUOT), a provider of intelligent security analytical technology solutions, has been awarded a contract for the validation and update of data center assets across multiple data centers of a major national retail chain.

"The validation and update services are critical steps in the data migration and application upgrade planning process in which the customer is now engaged. Utilizing our patented method for data center asset validation allows us to insure a quick turnaround with extremely high levels of accuracy, which is critical to this type of endeavor. We have successfully provided these services to many other Fortune 500 companies in the past utilizing this same methodology," stated Joe Coschera, Vice President of Duos' IT Infrastructure Services (ITIS) division.

Continue Reading


Company: FutureWorld Corp. (Pink Sheets: FWDG)


FutureWorld (FWDG) CB Scientific to Deliver Affordable Legal Global Access to Complete Cannabis Testing for Potency & Detection

CB Scientific & uPrep Make History by Giving Access to Patients & Growers to an Advanced Scientific Laboratory from Anywhere Without Boundaries Affordably

Denver, Colorado, Sept. 8, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (FWDG), a cannabis technology accelerator and a leading provider of advanced technologies and solutions to the global cannabis industry, announced today that its subsidiary, CB Scientific, a leading Cannabis (hemp) Science and Technology company, has signed an exclusive global distribution agreement with uPREP Laboratory Test Kits Inc. The agreement pairs uPrep's high-quality testing product portfolio and its industry-leading scientific laboratory testing, which enables quality assurance and patient safety within Cannabinoid Medicine, with CB Scientific's technological innovations and marketing expertise.

Continue Reading


Market News


By Evelyn Cheng : CNBC


Dow briefly adds 325; Nasdaq surges 2% into black for 2015

U.S. stocks traded sharply higher Tuesday, trying for recovery after the long weekend and their second-worst week for the year.

The major averages leaped about 2 percent or more in early trade, with the Dow Jones industrial average briefly gaining more than 325 points. Wal-Mart surged more than 3 percent to lead all blue chips higher.

The Nasdaq outperformed, rising more than 2.2 percent into the black for 2015, while the other two averages remain negative for the year so far.

Continue Reading


By Evelyn Cheng :
CNBC


Early movers: YUM, AET, STZ, DIS, PG, MSFT & more

Take a look at some of Tuesday's early movers:

JD.com - the Alibaba rival announced a share repurchase program of up to 1.0 billion dollars over the next 24 months. The firm plans to fund repurchases through its available cash balance.

Yum Brands - CLSA upgraded the fast food company to "buy" from "outperform" on expectations of recovery in the firm's China operations. CLSA also raised its price target from $105 to $107 a share for an upside of more than 35 percent from Friday's closing price of $78.89 a share.

Aetna - RBC upgraded the health insurance provider to "outperform" from "sector perform" on positive outlook, especially given the likely acquisition of Humana.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks